The stock is now holding below its 50-day SMA of $80.15 and below its 200-day SMA of $81.98.
AmerisourceBergen Corp. had a net margin of 1.14% and a return on equity of 83.93%.
AmerisourceBergen Corporation's (ABC) price volatility for a month noted as 1.97% however its price volatility for a week documented as 3.78%. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.22 per share. The business had revenue of $37.60 billion for the quarter, compared to the consensus estimate of $37.97 billion. After this transaction, the insider's stake stands at 1,022 shares, with a market value of $71325.
During last one month it showed the change of -5.67%. The difference between the actual and expected EPS is $0.1 a share with a surprise factor of 7.9%.
Earnings: AmerisourceBergen topped earnings in the reported quarter. Zacks Investment Research raised AmerisourceBergen Corp. from a sell rating to a hold rating and set a $94.00 price target on the stock in a research note on Monday, July 11th. AmerisourceBergen Corp. updated its FY17 guidance to $5.63-5.88 EPS. The 15 stock analysts who cover the stock have an average PT at $90.6, with individual targets in the range of $80 to $105. The firm lowered its rating on ABC from Mkt Outperform to Mkt Perform.
Some buy side analysts are also providing their Analysis on AmerisourceBergen Corporation, where 5 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 12 said it's a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. The Corporation has average brokerage recommendation (ABR) of 2.69 based on consensus of the brokerage firms issuing ratings. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. In this transaction, these shares were sold at value of $69.85 per share, according to the information disclosed by the Securities and Exchange Commission in a Form 4 filing on 01 Nov 2002. The $99.77 average target is 31.35% above today's ($75.96) stock price. Following the completion of the transaction, the insider now directly owns 104,043 shares in the company, valued at $8,916,485.10. The disclosure for this sale can be found here.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Massachusetts Financial Services Co. They are projecting Next Quarter growth of 2.4%. Now shares have been rated as Buy from 0 brokerage firms and 4 brokerage firms say as Strong Buy. Van ECK Associates Corp increased its position in AmerisourceBergen Corp.by 185.0% in the second quarter. The consensus price target (PT) of $91.27 means that the market expects Company shares to increase by 14.8% in the short run. APG Asset Management N.V. now owns 1,274,824 shares of the company's stock worth $101,119,000 after buying an additional 253,200 shares during the last quarter. Following the transaction, the insider now owns 9,436 shares in the company, valued at $844,522.
AmerisourceBergen Corporation provides pharmaceutical services.
In the latest quarter, pharmaceutical distribution revenue grew 5.9% to $36 billion, and revenue in its other businesses increased 4.9% to $1.63 billion. The Company also provides data and other services to its manufacturing customers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectible pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers.